Page last updated: 2024-09-04

u-91356 and Dyskinesia, Drug-Induced

u-91356 has been researched along with Dyskinesia, Drug-Induced in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bédard, PJ; Blanchet, PJ; Calon, F; Di Paolo, T; Goulet, M; Martel, JC; Piercey, MF1
Bédard, PJ; Blanchet, PJ; Calon, F; Di Paolo, T; Martel, JC; Piercey, MF; Walters, RR1

Other Studies

2 other study(ies) available for u-91356 and Dyskinesia, Drug-Induced

ArticleYear
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
    Brain research, 1995, May-22, Volume: 680, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aminoquinolines; Animals; Autoradiography; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Imidazoles; Levodopa; Macaca fascicularis; Parkinson Disease, Secondary; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA

1995
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:2

    Topics: Aminoquinolines; Animals; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Imidazoles; Macaca fascicularis; Motor Activity; MPTP Poisoning; Receptors, Dopamine D1; Receptors, Dopamine D2

1995